Press release
Chemotherapy Induced Nausea and Vomiting Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Discover the latest drugs and treatment options in the Chemotherapy Induced Nausea and Vomiting Pipeline. Dive into DelveInsight's comprehensive report today! @ Chemotherapy Induced Nausea and Vomiting Pipeline Outlook [https://www.delveinsight.com/sample-request/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Chemotherapy Induced Nausea and Vomiting Pipeline Report
* In May 2025, Arbeitsgemeinschaft medikamentoese Tumortherapie announced a phase III trial is to investigate the efficacy and safety of dronabinol (orally administered tetrahydrocannabinol (THC)) as adjuvant therapy to first-line standard chemotherapy in patients with metastatic pancreatic cancer for improvement of chemotherapy- and tumor-related symptoms applicated by individual titration up to the maximum tolerated dose.
* DelveInsight's Chemotherapy Induced Nausea and Vomiting Pipeline report depicts a robust space with 8+ active players working to develop 5+ pipeline therapies for Chemotherapy Induced Nausea and Vomiting treatment.
* The leading Chemotherapy Induced Nausea and Vomiting Companies such as Helsinn Healthcare SA, Acacia Pharma, Camurus, Benuvia Therapeutics, Aphios Corporation, Aphios Corporation, Zhuhai Beihai Biotech Co. Ltd, and others.
* Promising Chemotherapy Induced Nausea and Vomiting Pipeline Therapies such as GW679769, Dexamethasone, Ondansetron Hydrochloride, Palonosetron Hydrochloride Buccal Film 0.25 Mg, Akynzeo, Fosaprepitant Dimeglumine and others.
Stay ahead with the most recent pipeline outlook for Chemotherapy Induced Nausea and Vomiting. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Chemotherapy Induced Nausea and Vomiting Treatment Drugs [https://www.delveinsight.com/sample-request/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Chemotherapy Induced Nausea and Vomiting Emerging Drugs Profile
* Fosnetupitant: Helsinn Healthcare SA
Fosnetupitant is an NK1 receptor antagonist antiemetic drug developed for the prevention of chemotherapy-induced nausea and vomiting. It is a phosphorylated pro-drug preparation (injection) of netupitant, the active component. The prevention of chemotherapy-induced nausea and vomiting is considered important in clinical practice. Taiho acquired exclusive development and marketing rights for fosnetupitant in Japan under a license agreement signed in April 2011 with Helsinn Healthcare SA and has conducted clinical trials in Japan since then. The new drug application is based on the results of a Phase III clinical trial comparing the efficacy and safety of fosnetupitant and fosaprepitant (NK1 receptor antagonist) in patients receiving highly emetogenic chemotherapy. In the trial, either fosnetupitant (235 mg) or fosaprepitant (150 mg) was administered in a single I.V. dose prior to administration of the chemotherapeutic agent, in combination with palonosetron (5-HT3 receptor antagonist) and dexamethasone. Currently, the drug is in Registration stage of its development for the treatment of chemotherapy induced nausea and vomiting.
* APD403: Acacia Pharma
APD403 is based on the selective dopamine antagonist amisulpride. It is being developed as an intravenous injection for cancer patients to be administered immediately before they receive chemotherapy to prevent acute CINV, and as an oral tablet to prevent delayed CINV. Currently the drug is in Phase II stage of development for the treatment of Chemotherapy Induced Nausea and Vomiting.
* CAM2047: Camurus
CAM2047 is a long-acting subcutaneous granisetron depot for in development for the treatment of acute and delayed chemotherapy-induced nausea and vomiting. Currently the drug is in Phase I stage of development for the treatment of Chemotherapy Induced Nausea and Vomiting.
The Chemotherapy Induced Nausea and Vomiting Pipeline Report Provides Insights into
* The report provides detailed insights about companies that are developing therapies for the treatment of Chemotherapy Induced Nausea and Vomiting with aggregate therapies developed by each company for the same.
* It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Chemotherapy Induced Nausea and Vomiting Treatment.
* Chemotherapy Induced Nausea and Vomiting Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
* Chemotherapy Induced Nausea and Vomiting Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
* Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Chemotherapy Induced Nausea and Vomiting market
Explore groundbreaking therapies and clinical trials in the Chemotherapy Induced Nausea and Vomiting Marketed and Pipeline Drugs. Access DelveInsight's detailed report now! @ New Chemotherapy Induced Nausea and Vomiting Drugs [https://www.delveinsight.com/sample-request/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Chemotherapy Induced Nausea and Vomiting Companies
Helsinn Healthcare SA, Acacia Pharma, Camurus, Benuvia Therapeutics, Aphios Corporation, Aphios Corporation, Zhuhai Beihai Biotech Co. Ltd, and others.
Chemotherapy Induced Nausea and Vomiting pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
* Oral
* Intravenous
* Subcutaneous
* Parenteral
* Topical
Chemotherapy Induced Nausea and Vomiting Products have been categorized under various Molecule types such as
* Recombinant fusion proteins
* Small molecule
* Monoclonal antibody
* Peptide
* Polymer
* Gene therapy
Unveil the future of Chemotherapy Induced Nausea and Vomiting Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ Chemotherapy Induced Nausea and Vomiting Market Drivers and Barriers [https://www.delveinsight.com/sample-request/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Chemotherapy Induced Nausea and Vomiting Pipeline Report
* Coverage- Global
* Chemotherapy Induced Nausea and Vomiting Companies- Helsinn Healthcare SA, Acacia Pharma, Camurus, Benuvia Therapeutics, Aphios Corporation, Aphios Corporation, Zhuhai Beihai Biotech Co. Ltd, and others.
* Chemotherapy Induced Nausea and Vomiting Pipeline Therapies- GW679769, Dexamethasone, Ondansetron Hydrochloride, Palonosetron Hydrochloride Buccal Film 0.25 Mg, Akynzeo, Fosaprepitant Dimeglumine and others.
* Chemotherapy Induced Nausea and Vomiting Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Chemotherapy Induced Nausea and Vomiting Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Get the latest on Chemotherapy Induced Nausea and Vomiting Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Chemotherapy Induced Nausea and Vomiting Companies, Key Products and Unmet Needs [https://www.delveinsight.com/sample-request/chemotherapy-induced-nausea-and-vomiting-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Contents
* Introduction
* Executive Summary
* Chemotherapy Induced Nausea and Vomiting: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Chemotherapy Induced Nausea and Vomiting - DelveInsight's Analytical Perspective
* In-depth Commercial Assessment
* Chemotherapy Induced Nausea and Vomiting Collaboration Deals
* Late Stage Products (Registration)
* Fosnetupitant: Helsinn Healthcare SA
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* APD403: Acacia Pharma
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* CAM2047: Camurus
* Drug profiles in the detailed report.....
* Preclinical and Discovery Stage Products
* Drug Name: Company Name
* Drug profiles in the detailed report.....
* Inactive Products
* Chemotherapy Induced Nausea and Vomiting Key Companies
* Chemotherapy Induced Nausea and Vomiting Key Products
* Chemotherapy Induced Nausea and Vomiting- Unmet Needs
* Chemotherapy Induced Nausea and Vomiting- Market Drivers and Barriers
* Chemotherapy Induced Nausea and Vomiting- Future Perspectives and Conclusion
* Chemotherapy Induced Nausea and Vomiting Analyst Views
* Chemotherapy Induced Nausea and Vomiting Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=chemotherapy-induced-nausea-and-vomiting-pipeline-appears-robust-with-8-key-pharma-companies-actively-working-in-the-therapeutics-segment-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/chemotherapy-induced-nausea-and-vomiting-pipeline-insight
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chemotherapy Induced Nausea and Vomiting Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight here
News-ID: 4043523 • Views: …
More Releases from ABNewswire
The Essential Guide to U-Bolts - Specifications and Industry Applications
In the world of heavy-duty trucks, where every component must withstand immense stress, one humble part plays a disproportionately critical role: the U-bolt [https://www.jqtruckparts.com/u-bolt/]. Though simple in design, this fastener is essential for vehicle safety, performance, and stability.
Image: https://www.jqtruckparts.com/uploads/U%E5%9E%8B3.jpg
What is a U-Bolt? A U-bolt is a U-shaped mounting bolt made from high-strength steel rod,with threaded ends fitted with nuts and washers. Its primary function is to securely clamp the axle…
What is the difference between a hinge and a door hinge?
Hinges are essential components in the world of furniture hardware, being the key connections that enable various structures to open and close smoothly. Although the terms "hinge" and "Door Hinge [https://www.monsoonhardware.com/door-hinge/]" are often used interchangeably, they refer to different applications with different characteristics that meet specific needs. Understanding these differences is essential for anyone involved in construction, renovation or furniture design.
A hinge is essentially a mechanical device that connects two…
CNC Electric Strengthens Partnership with BI GROUP in Kazakhstan
CNC Electric Strengthens Partnership with BI GROUP in Kazakhstan
CNC Electric is proud to announce a significant milestone in our collaboration with BI GROUP, one of Kazakhstan's leading real estate developers. By joining BI GROUP's approved vendor roster, CNC Electric is now positioned to support new large-scale projects and expand our presence across the region.
Prior to This Collaboration
Key BI GROUP specialists visited our China manufacturing facility, where they firsthand verified CNC…
How to convert process pipelines into instrument pipelines? Hikelok provides wit …
First, let's understand what a process pipeline is? What is an instrument pipeline.
Process pipeline: a pipeline used for conveying, distributing, mixing, separating, discharging, metering, controlling, and buffering fluid flow. Simply put, it refers to the main pipelines of oil, petrochemical, chemical and other plants, and the process pipelines are designed by process designers.
Instrument pipeline: Signal piping in contact with process fluids and temperature pressure conditions. Usually used for measuring temperature,…
More Releases for Chemotherapy
Chemotherapy Devices Market - Innovation for Life: Chemotherapy Devices Driving …
Newark, New Castle, USA: The "Chemotherapy Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Chemotherapy Devices Market: https://www.growthplusreports.com/report/chemotherapy-devices-market/8623
This latest report researches the industry structure, sales, revenue,…
Chemotherapy Devices Market 2022 Will Boom With Advanced Chemotherapy Technologi …
New Research Study ""Chemotherapy Devices Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook"" has been added to Coherent Market insight
The most recent Global Chemotherapy Devices Market report includes a high-level overview of the industry as well as in-depth analysis of key areas. The overview presented highlights the definition of products and services, as well as their associated applications, at the…
Cancer, chemotherapy and its treatment
Chemotherapy is one of the most commonly used cancer therapies. It employs the use of certain medications to destroy cancer cells or prevent them from spreading to other parts of the body. Chemotherapy may be prescribed alone or in combination with surgery or radiation therapy. Along with chemotherapy, you may also take newer types of cancer-fighting medications.
Chemotherapy can be taken as pills or as injections. You may visit a clinic…
Chemotherapy induced Nausea and Vomiting (CINV) TreatmentS Market Driven by Risi …
According to WHO cancer is one of the most leading causes for death with around 8 million deaths and 14 million new patients in 2012. Chemotherapy, which is received by approximately four million cancer patients each year, is among the most commonly used treatment to fight cancer. However, this mode of treatment has many side effects, an estimate of around 70% - 80% of the patients receiving chemotherapy treatment experience…
Nano Chemotherapy Market Nano Chemotherapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Nano Chemotherapeutics Mediations andndash; Solicitation to Nanomedicine
1.1 Overview
1.2 Nano Chemotherapeutics with Pharmaceutical Potential
Significance of Nano Chemotherapeutics to overcome the Chemotherapy Limitations
2.1 Limitations of Conventional Chemotherapy
2.2 Nanotechnology in Cancer Targeting
2.2.1 Active Targeting
2.2.2 Passive Targeting
2.2.3 pH Dependent Drug Delivery Through Nanoparticles
Role…
Nano Chemotherapy Is Emerging As An Important Anti-Cancer Modality By Supplement …
“Global Nano Chemotherapy Market and Clinical Trials Outlook 2022” report highlights the current development in the in the field of nano chemotherapy. Report gives comprehensive insight on various clinical and non-clinical parameters associated with the expansion of global nano chemotherapeutics market. The clinical and pricing insight on chemotherapeutics nanoformulations of approved drugs helps to understand the current market scenario of the nano chemotherapeutics.
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Download Report:…
